Bone Biologics Co. (OTC:BBLG – Get Free Report)’s share price fell 0.7% during trading on Thursday . The stock traded as low as $1.42 and last traded at $1.51. 42,286 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 104,567 shares. The stock had previously closed at $1.52.
Bone Biologics Trading Down 0.7 %
The stock has a market capitalization of $806,340.00, a price-to-earnings ratio of -0.03 and a beta of 0.24. The stock’s 50 day moving average is $1.87 and its 200 day moving average is $2.28.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
See Also
- Five stocks we like better than Bone Biologics
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- What is a Short Call Butterfly Spread? Explanation with Examples
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- Stock Average Calculator
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
